Caruso Cristiano, Valluzzi Rocco Luigi, Colantuono Stefania, Gaeta Francesco, Romano Antonino
Allergy Unit, Columbus Hospital, Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy.
Department of Pediatrics, Division of Allergy, Pediatric Hospital Bambino Gesù, Rome, Vatican City, Italy.
J Asthma Allergy. 2021 Jan 18;14:31-46. doi: 10.2147/JAA.S242061. eCollection 2021.
β-Lactams which include penicillins, cephalosporins, carbapenems, and monobactams are the most common antibiotic classes reported to cause allergic reactions to drugs. This review is mainly about published studies assessing the cross-reactivity among β-lactams in penicillin- or cephalosporin-allergic subjects by carrying out diagnostic tests with alternative β-lactams and, if appropriate, graded challenges. Several studies demonstrated that cross-reactivity connected with the β-lactam ring, causing positive responses to allergy tests with all β-lactams, is infrequent in subjects with an IgE-mediated allergy and anecdotal in those with a T-cell-mediated allergy. Identities or similarities of β-lactam side-chain structures are mainly responsible for cross-reactivity among these antibiotics. For example, in aminopenicillin-allergic subjects, cross-reactivity with aminocephalosporins could possibly be over 30%. On the other hand, in a few prospective studies of penicillin-allergic individuals, less than 1% of cases show a cross-reactivity between penicillins and both aztreonam and carbapenems. Particular patterns of allergy-test positivity observed in some studies that assessed cross-reactivity among β-lactams seem to indicate that prior exposures may be responsible for coexisting sensitivities. Therefore, pre-treatment skin tests with the related β-lactams are suggested before administering them via graded challenges to β-lactam-allergic patients who need alternative β-lactams.
β-内酰胺类药物包括青霉素类、头孢菌素类、碳青霉烯类和单环β-内酰胺类,是报告中最常引起药物过敏反应的抗生素类别。本综述主要涉及已发表的研究,这些研究通过使用替代β-内酰胺类药物进行诊断测试,并在适当情况下进行分级激发试验,来评估青霉素或头孢菌素过敏受试者中β-内酰胺类药物之间的交叉反应性。多项研究表明,与β-内酰胺环相关的交叉反应性,即对所有β-内酰胺类药物的过敏试验均呈阳性反应,在IgE介导的过敏受试者中并不常见,在T细胞介导的过敏受试者中则属罕见。β-内酰胺类药物侧链结构的相同或相似是这些抗生素之间交叉反应性的主要原因。例如,在对氨基青霉素过敏的受试者中,与氨基头孢菌素的交叉反应性可能超过30%。另一方面,在一些针对青霉素过敏个体的前瞻性研究中,不到1%的病例显示青霉素与氨曲南和碳青霉烯类药物之间存在交叉反应性。在一些评估β-内酰胺类药物交叉反应性的研究中观察到的特定过敏试验阳性模式似乎表明,既往接触可能是共存敏感性的原因。因此,对于需要替代β-内酰胺类药物的β-内酰胺类过敏患者,建议在通过分级激发试验给药之前,先用相关β-内酰胺类药物进行预处理皮肤试验。